Leqembi Approval Causes A Ripple Effect For Precision In Alzheimer’s

Insights From AC Immune CEO, Andrea Pfeifer

 
• By David Wild
  
For AC Immune, Targeting Amyloid Plaques Is One Part Of A Bigger Therapeutic Strategy • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Innovation

More from In Vivo